BridgeMD
New treatment option for Reproductive Issues
Official title A Novel Integrative Non-invasive Embryo Selection Approach for IVF Based on MK-RS Analysis
ClinicalTrials.gov ID: NCT05896709
What this study is testing
- What it's testing
- During assisted reproductive technology treatment, embryo selection is an important process that may affect the clinical pregnancy rate. Many assisted reproductive technology units over the world have tried different approaches to increase the clinical pregnancy rate.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- Patients undergoing IVF/ ICSI treatment
- Patients receiving the first, second or third IVF/ICSI treatment cycle
- Patients and their partners willing to sign the informed consent agreement
- Patients having at least three normal fertilised embryos on the day of the fertilization check
- Consecutive women undergoing IVF treatment
You likely can't join if
- Day one human embryos with blur imaging
- Large obstructions in the embryo area
- More than half of the embryo area is blocked by the well or degeneration
- Patients with more than half of the embryos without sufficient spent culture medium for RS analysis
- Patients with known genetic diseases
See the full eligibility criteria
- Patients undergoing IVF/ ICSI treatment
- Patients receiving the first, second or third IVF/ICSI treatment cycle
- Patients and their partners willing to sign the informed consent agreement
- Patients having at least three normal fertilised embryos on the day of the fertilization check
- Consecutive women undergoing IVF treatment
- Patients planning to use a time-lapse incubator for embryo culture
- Day one human embryos with blur imaging
- Large obstructions in the embryo area
- More than half of the embryo area is blocked by the well or degeneration
- Patients with more than half of the embryos without sufficient spent culture medium for RS analysis
- Patients with known genetic diseases
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.